CONTOUR® NEXT - Blood Glucose Test Strips - 35 Test Strips (per - ASCENSIA DIABETES CARE US INC.

Duns Number:080028910

Device Description: Blood Glucose Test Strips - 35 Test Strips (per bottle) - sold in a carton of 2 bottles (7 Blood Glucose Test Strips - 35 Test Strips (per bottle) - sold in a carton of 2 bottles (70 test strips total).

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

7278

Brand Name

CONTOUR® NEXT

Version/Model Number

7278

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

Yes

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K121190,K160430,K162336,P150001,P160017,K121190,K160430,K162336,P150001,P160017,K121190,K160430,K162336,P150001,P160017,P160017,P150001,K162336,K160430,K121190

Product Code Details

Product Code

LFR

Product Code Name

Glucose Dehydrogenase, Glucose

Device Record Status

Public Device Record Key

10a8c694-48db-4d58-b837-910520d11ed4

Public Version Date

July 06, 2018

Public Version Number

3

DI Record Publish Date

November 03, 2017

Additional Identifiers

Package DI Number

40301937278707

Quantity per Package

12

Contains DI Package

00301937278709

Package Discontinue Date

-

Package Status

In Commercial Distribution

Package Type

case

"ASCENSIA DIABETES CARE US INC." Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 7
2 A medical device with a moderate to high risk that requires special controls. 19
3 A medical device with high risk that requires premarket approval 2